K.R.R. Drugs & Intermediates Private Limited

K.R.R. Drugs & Intermediates Private Limited - pharma in Hyderabad, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24239AP2002PTC038417 Incorporated 30 January 2002 ROC Vijayawada HQ Hyderabad, Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹6.26 Lakh
▼ 99% YoY
Net loss · FY 2025
₹20.2 Lakh
Net margin -322.7%
EBITDA · FY 2025
-₹15.68 Lakh
EBITDA margin -250.5%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Satisfied charges
₹15.43 Cr
No open charges
Company age
24 yrs
Est. 2002
Employees · EPFO
6
Provident fund records

About K.R.R. Drugs & Intermediates Private Limited

Data last updated:

K.R.R. Drugs & Intermediates Private Limited is a private limited company based in Hyderabad, Andhra Pradesh, India, a subsidiary of Glochem Industries Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 30 January 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2002PTC038417. Its GSTIN is 37AADCM9037F2ZC (Andhra Pradesh). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹25 Lakh. It was formerly known as Medeva Laboratories Private Limited. It is led by directors Subbarao Kattamuri and Sushma Kattamuri.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No.406 Aditya Trade Centre, Hyderabad, Andhra Pradesh, India – 500038.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.26 Lakh, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹20.2 Lakh (net margin -322.7%) and EBITDA of -₹15.68 Lakh (EBITDA margin -250.5%). Revenue has grown at a compounded annual rate (CAGR) of 266% over three years and 106% over five years.

The company has about 6 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹15.43 Cr on record. Court records list 10 cases involving the company, including 2 filed by the company and 8 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website krrdrugs.com.

Company details

CIN U24239AP2002PTC038417
Registration Number 038417
Incorporation Date 30 January 2002
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Parent Company Glochem Industries Private Limited
Compliance Status Active Compliant

Contact details

K.R.R. Drugs & Intermediates Private Limited's registered office is in Hyderabad, Andhra Pradesh. Its website is krrdrugs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No.406 Aditya Trade Centre, Hyderabad, Andhra Pradesh, India – 500038
  • Industry
    Pharma, API Manufacturers

To see the full contact details of K.R.R. Drugs & Intermediates Private Limited, buy the company report.

Comprehensive company report
K.R.R. Drugs & Intermediates Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of K.R.R. Drugs & Intermediates is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of K.R.R. Drugs & Intermediates Private Limited, buy the company report.

Financials of K.R.R. Drugs & Intermediates Private Limited

FY 2024 filings available

K.R.R. Drugs & Intermediates Private Limited reported revenue of ₹6.26 Lakh (down 99% YoY) for FY 2025.

Revenue · FY 2025
₹6.26 Lakh ▼ 99%
Net loss · FY 2025
₹20.2 Lakh margin -322.7%
EBITDA · FY 2025
-₹15.68 Lakh margin -250.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 99%
3 years · compounded
▲ 266%
5 years · compounded
▲ 106%
EBITDA CAGR growth
1 year
▼ 102%
3 years · compounded
▲ 39%
5 years · compounded
▲ 22%

Revenue fell 99% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 106%. EBITDA fell 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹15.68 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹20.2 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-250.5%
Net Profit Margin-322.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of K.R.R. Drugs & Intermediates Private Limited, buy the company report.

Board of directors of K.R.R. Drugs & Intermediates Private Limited

K.R.R. Drugs & Intermediates has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Subbarao KattamuriDirector08 Jul 201511 Years 3 MonthsCurrent
Sushma KattamuriDirector13 Aug 20242 Years 2 MonthsCurrent

Auditor

K.R.R. Drugs & Intermediates Private Limited is audited by Rajesh Lakshman & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Rajesh Lakshman & AssociatesFY 202308225S

Shareholding

The shareholding of K.R.R. Drugs & Intermediates Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of K.R.R. Drugs & Intermediates Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹15.43 Cr
Breakdown by lending institutions
Syndicate Bank₹12.60 Cr
Central Bank of India₹2.83 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Oct 201410532574Syndicate Bank₹7.4 CrSatisfied
01 Aug 200580055617Syndicate Bank₹2.75 CrSatisfied
01 Aug 200590133288Syndicate Bank₹1.14 CrSatisfied
08 Jun 200590133275Syndicate Bank₹1.31 CrSatisfied
22 Mar 200490136658Central Bank of India₹2.83 CrSatisfied

To see the full charge records of K.R.R. Drugs & Intermediates Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for K.R.R. Drugs & Intermediates Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

K.R.R. Drugs & Intermediates Private Limited has a workforce of 6 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.

Employee count
6
Active EPFO establishments
1

GST

K.R.R. Drugs & Intermediates has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
37AADCM9037F2ZCAndhra PradeshActive01 Jul 2017
36AADCM9037F1ZFTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of K.R.R. Drugs & Intermediates Private Limited, buy the company report.

Recent activity

K.R.R. Drugs & Intermediates Private Limited has 14 board changes on record since 2006: 2 appointments and 12 cessations. The latest: Sushma Kattamuri ceased to be Additional Director on 29 Sep 2024.

AGM
K.R.R. Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Sushma Kattamuri ceased to be Additional Director.
Appointed
Sushma Kattamuri was appointed as Director.
Filing
K.R.R. Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Ceased
Vamsi Krishna Vanteru ceased to be Whole-Time Director.
Ceased
Venugopal Reddy Vanteru ceased to be Managing Director.
Ceased
Kalyan Nagururu ceased to be Additional Director.
Ceased
Subbarao Kattamuri ceased to be Additional Director.
Ceased
Sundeep Kattamuri ceased to be Additional Director.
Appointed
Subbarao Kattamuri was appointed as Director.
Ceased
Murali Krishnam Raju Vadlamudi ceased to be Additional Director.
Ceased
Venkata Alluri Raju ceased to be Additional Director.

18 earlier events are in the company report.

Frequently asked questions

K.R.R. Drugs & Intermediates is an active private limited company based in Hyderabad, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 30 January 2002 (24+ years old) and is registered under CIN U24239AP2002PTC038417.

K.R.R. Drugs & Intermediates has 2 current directors:

The latest financial statements of K.R.R. Drugs & Intermediates on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of K.R.R. Drugs & Intermediates is 37AADCM9037F2ZC, registered in Andhra Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AADCM9037F1ZF (Telangana).

The CIN (Corporate Identification Number) of K.R.R. Drugs & Intermediates is U24239AP2002PTC038417. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

K.R.R. Drugs & Intermediates has 10 court cases on record: 2 filed by the company and 8 filed against it. Most are in the district courts.

K.R.R. Drugs & Intermediates was incorporated on 30 January 2002, making it 24+ years old. It is registered with the Registrar of Companies, Vijayawada.

Sushma Kattamuri ceased to be Additional Director on 29 Sep 2024. Sushma Kattamuri was appointed as Director on 13 Aug 2024. Vamsi Krishna Vanteru ceased to be Whole-Time Director on 20 Dec 2023. K.R.R. Drugs & Intermediates has 14 board changes on record in total.

K.R.R. Drugs & Intermediates can be reached through the website krrdrugs.com. Its registered office is in Hyderabad, Andhra Pradesh, India.

The registered office of K.R.R. Drugs & Intermediates is at Flat No.406 Aditya Trade Centre, Hyderabad, Andhra Pradesh, India – 500038.